For instance, Shapiro has explored ILT and its potential use, and has demonstrated that ILT does possess the ability and validity to correct HbA1c concentrations to certain values that may reverse the secondary consequences of diabetes [17], while insulin administration via pump or similar set-ups may result in fewer or attenuated effects on concentrations of the diabetic biomarker HbA1C [18]. This evidence concerns the gene INS and diabetes mellitus.